Mitchell Cairo, MD
Enriched profileVice Chair and Professor of Pediatrics; Chief, Pediatric Hematology, Oncology and Stem Cell Transplantation · New York Medical College
Mitchell Cairo is Vice Chair and Professor of Pediatrics; Chief, Pediatric Hematology, Oncology and Stem Cell Transplantation at New York Medical College. OpenAlex indexes 1,026 publications with 27,810 citations (h-index 84); ClinicalTrials.gov lists 44 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Hematology / Oncology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Mitchell S. Cairo, MD, is Vice Chair and Professor of Pediatrics at New York Medical College / Westchester Medical Center (Maria Fareri Children's Hospital), Valhalla, NY. The public record shows 1,026 publications with 27,810 citations (h-index 84), centered on Hematopoietic Stem Cell Transplantation, Lymphoma Diagnosis and Treatment, Acute Lymphoblastic Leukemia research. It also documents an investigator role on 44 registered clinical trials, industry payments reported by 20 companies, 9 NIH-funded awards (2002–2026).
- Most recent indexed publication: 2026 · Journal for immunotherapy of cancer
- Top research focus: Hematopoietic Stem Cell Transplantation
- 44 registered trials on ClinicalTrials.gov
- Open Payments reporting from 20 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 41 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 371.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 44 registered studies on ClinicalTrials.gov. The most recent:
- CD30 CAR-T Cells for Low Risk Relapsed Classical Hodgkin Lymphoma
Sponsor: New York Medical College
- Phase 3 Randomized Trial for Refractory ADV or CMV Infection With Family Matched CTLs and Standard of Care (SOC) vs SOC Alone
Sponsor: New York Medical College
- Chemoimmunotherapy for ALK+ Relapsed/Refractory ALCL
Sponsor: New York Medical College
Industry payments
Updated 27 Aug 2026
20 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- JAZZ PHARMACEUTICALS INC.Program year202563 payments$75,365openpaymentsdata.cms.gov ↗
- Kite Pharma, Inc.Program year20256 payments$34,982openpaymentsdata.cms.gov ↗
- Amgen Inc.Program year202528 payments$33,816openpaymentsdata.cms.gov ↗
NIH funding
Updated 27 Aug 2026
9 NIH research awards on record, funded 2002–2026 per NIH RePORTER. The latest:
- A Randomized Study of Maternal Donor Derived CMV Cytotoxic T-Lymphocytes (CTLs) and Valganciclovir vs Valganciclovir in Neonates With Moderate/Severe Maternal Acquired CMV Infection
New York Medical College
FY2026$324,998R01FD007837 - A Randomized Study of Maternal Donor Derived CMV Cytotoxic T-Lymphocytes (CTLs) and Valganciclovir vs Valganciclovir in Neonates With Moderate/Severe Maternal Acquired CMV Infection
New York Medical College
FY2025$324,998R01FD007837 - A Randomized Study of Maternal Donor Derived CMV Cytotoxic T-Lymphocytes (CTLs) and Valganciclovir vs Valganciclovir in Neonates With Moderate/Severe Maternal Acquired CMV Infection
New York Medical College
FY2023$649,999R01FD007837
Congress activity
Updated 27 Aug 2026
100 congress contributions (1997–2025) across AACR, ASCO, ASH, ESMO per OpenAlex. The most recent:
- Enhancing CD33.CAR NK cell therapy for acute myeloid leukemia through TGFβ imprinting and NKTR-255
ASH Annual Meeting
ASH2025Co-author - Identification of the MIF-CD74/CD44 signaling axis as a therapeutic target in pediatric Acute Myeloid Leukemia
ASH Annual Meeting
ASH2025Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Circumventing Ewing sarcoma tumor microenvironment resistance by IL1RAP CAR-modified TGFβ1-imprinted natural killer cells in combination with IL-15 agonist and anti-GD2 antibody.
Journal for immunotherapy of cancer
Article2026 - Rasburicase vs. allopurinol: mortality in hematological malignancies post anti-hyperuricemic therapy - real-world study.
Supportive care in cancer
Article2025 - CD19 CAR T-Cell Therapy for Primary Mediastinal Large B-Cell Lymphoma: A CIBMTR Analysis.
American journal of hematology
Article2025 - CAR-NK's balancing act: when scFv affinity is not too tight, not too loose… but just right?
Journal for immunotherapy of cancer
Article2025
Most-cited works
by citation count (OpenAlex)Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/mitchell-cairo-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- LinkedIn
rs.linkedin.com/posts/new-york-medical-college_mitchell-s-cairo-md-awarded-research-activity-7021189487992954881-GVPu
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rs.linkedin.com ↗ - LinkedIn
linkedin.com/posts/new-york-medical-college_nymc-nymcsom-nymcgsbms-activity-7173739785658728449-D_Zc
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/scientific-contributions/Mitchell-S-Cairo-39305876
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nymc.edu ↗
- B.A.
University of Wisconsin
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nymc.edu ↗ - Residency in Pediatrics
UCLA/Harbor General Hospital
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nymc.edu ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nymc.edu ↗
- Fellowship in Pediatric Hematology/Oncology
Indiana University
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nymc.edu ↗ - Board Certified
Pediatrics
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nypedscbc.org ↗ - Board Certified
Pediatric Hematology-Oncology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healthgrades.com ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nymc.edu ↗
- Chief
Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, New York Medical College
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nymc.edu ↗ - Director
Children and Adolescent Cancer and Blood Diseases Center, Maria Fareri Children's Hospital at Westchester Medical Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nymc.edu ↗
Awards & honors
honors on the public record- Department of Defense Translational Team Science Award
$2.6 million (T-cell ALL/lymphoblastic lymphoma research)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nymc.edu ↗
Secondary affiliations
appointments beyond the home institution- Professor of Medicine
Pathology, Microbiology and Immunology, and Cell Biology and Anatomy, New York Medical College
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nymc.edu ↗ - Professor of Public Health
New York Medical College
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →nymc.edu ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →onclive.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →vjhemonc.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Leslie Citrome, MD, MPH
New York Medical College
Jerry Nadler
New York Medical College
Karen Seiter, MD
New York Medical College
Allen Dozor, MD
New York Medical College